Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PREP | P48147 | 3/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.63 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | KLK7 | P49862 | 1/20 | 0.60 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | GFER | P55789 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL475715 | 1.00 | PREP (0.67) | PREPALDH1A1SMN1; SMN2CTRB1NPSR1 | |
| SCHEMBL29658848 | 1.00 | PREP (0.67) | PREPALDH1A1SMN1; SMN2CTRB1NPSR1 | |
| SCHEMBL29553 | 1.00 | PREP (0.67) | PREPALDH1A1SMN1; SMN2CTRB1NPSR1 | |
| Hydrochloric Acid SCHEMBL32677508 | 0.99 | PREP (0.65) | PREPALDH1A1SMN1; SMN2CTRB1NPSR1 | |
| SCHEMBL630208 | 0.96 | PREP (0.62) | PREPALDH1A1SMN1; SMN2CTRB1NPSR1 | |
| SCHEMBL82714 | 0.96 | PREP (0.62) | PREPALDH1A1SMN1; SMN2CTRB1NPSR1 | |
| SCHEMBL630241 | 0.96 | PREP (0.62) | PREPALDH1A1SMN1; SMN2CTRB1NPSR1 | |
| SCHEMBL18093534 | 0.95 | PREP (0.71) | PREPALDH1A1SMN1; SMN2CTRB1NPSR1 | |
| SCHEMBL20678314 | 0.95 | PREP (0.71) | PREPALDH1A1SMN1; SMN2CTRB1NPSR1 | |
| SCHEMBL17459415 | 0.95 | PREP (0.71) | PREPALDH1A1SMN1; SMN2CTRB1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 553 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112079678-B | Method for constructing carboxylic acid or alcohol by olefin remote functionalization | 四川大学 | 2021-12-21 | — | — | CN | claimed |
| CN-112079678-A | Method for constructing carboxylic acid or alcohol by olefin remote functionalization | 四川大学 | 2020-12-15 | — | — | CN | claimed |
| CN-108610358-B | 3- (trimethylsilyl) pyrrolidine-2-carboxylic acid, intermediate thereof, preparation and application | 上海交通大学 | 2020-08-25 | — | — | CN | claimed |
| EP-0817795-B1 | NOVEL 4-SUBSTITUTED-3-PEPTIDYL-AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE INHIBITOR | NAEJA PHARMACEUTICAL INC (CA) | 2000-11-15 | — | — | EP | claimed |
| EP-0817795-A1 | NOVEL 4-SUBSTITUTED-3-PEPTIDYL-AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE INHIBITOR | SYNPHAR LABORATORIES INC. (CA) | 1998-01-14 | — | — | EP | claimed |
| WO-1996032408-A1 | NOVEL 4-SUBSTITUTED-3-PEPTIDYL-AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE INHIBITOR | SYNPHAR LABORATORIES, INC. (US) | 1996-10-17 | — | — | WO | claimed |
| EP-0384341-A2 | New proline derivatives | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 1990-08-29 | — | — | EP | claimed |
| US-4434095-A | Cyclic analogue of naturally-occurring phagocytosis-stimulant peptide - threonyl-cyclo-[-N.sup.ε -lysyl-prolyl-arginyl] | INSTITUTE ORGANICHESKOGO SINTEZA (SU) | 1984-02-28 | — | — | US | claimed |
| JP-55064556-A | — | — | None | — | — | JP | disclosed |
| JP-1068396-A | — | — | None | — | — | JP | disclosed |
| JP-5271187-A | — | — | None | — | — | JP | disclosed |
| US-12625431-B2 | EUV resist underlayer film-forming composition | NISSAN CHEMICAL CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| US-20250313572-A1 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | ABBVIE INC (US) | 2025-10-09 | — | — | US | disclosed |
| EP-4494698-A2 | INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2025-01-22 | — | — | EP | disclosed |
| US-4179437-A | Amino acid derivatives of 6-(2-amino-2-arylacetamido) penicillanic acids | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1979-12-18 | — | — | US | disclosed |
| US-4111932-A | BACTERICIDE | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1978-09-05 | — | — | US | disclosed |
| US-4093610-A | CYCLIC DODECAPEPTIDE, MULTISTAGE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |
| US-4081533-A | INHIBITION OF LUTENIZING HORMONE, USING A NONAPEPTIDE, 8-ARGINE-VASOTOCIN, OR A TRIPEPTIDE, PROPYL-ARGINYL-GLYCINAMIDE | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1978-03-28 | — | — | US | disclosed |
| US-3976660-A | Pyrrolidine derivatives | E. R. SQUIBB & SONS, INC. (US) | 1976-08-24 | — | — | US | disclosed |
| US-3947408-A | ANTIANXIETY AGENTS | AMERICAN CYANAMID COMPANY (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12625431-B2 | EUV resist underlayer film-forming composition | EEF1A1, ARF1, EMG1 | PREP 4442/4885ALDH1A1 2046/4885SMN1; SMN2 3129/4885 |
| US-20250313572-A1 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | MCL1, BCL2A1, BCL2L10 | PREP 4854/4885ALDH1A1 641/4885SMN1; SMN2 605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.